LGD-2226
LGD-2226
CAS: 328947-93-9
Molecular Formula: C14H9F9N2O
LGD-2226 - Names and Identifiers
LGD-2226 - Physico-chemical Properties
| Molecular Formula | C14H9F9N2O |
| Molar Mass | 392.22 |
| Density | 1.526±0.06 g/cm3(Predicted) |
| Melting Point | 187-190°C |
| Boling Point | 364.4±42.0 °C(Predicted) |
| Solubility | DMSO (Slightly), Methanol (Slightly) |
| Appearance | Solid |
| Color | Pale Yellow to Light Yellow |
| BRN | 10716241 |
| pKa | 9.88±0.70(Predicted) |
| Storage Condition | -20°C Freezer, Under inert atmosphere |
LGD-2226 - Risk and Safety
| Hazard Symbols | Xn - Harmful |
| Risk Codes | 48/22 - Harmful danger of serious damage to health by prolonged exposure if swallowed. |
| WGK Germany | 3 |
| RTECS | VC8275240 |
LGD-2226 - Introduction
LGD-2226(LGD-2226) is a chemical that belongs to the group of selective androgen receptor modulators (SARMs). It has effects similar to androgens, but it acts selectively on the androgen receptor to reduce or avoid undesirable androgen-related side effects.
LGD-2226 are mainly used to strengthen muscle mass and strength, and are widely used in fitness and sports fields. Its mechanism of action is to promote muscle growth and repair by binding to androgen receptors in muscles and increasing protein synthesis.
As for the preparation method, the specific synthesis method of the LGD-2226 may be confidential commercial information, and I cannot provide a detailed preparation process.
Regarding safety information, there is no large-scale human trial data for reference. The use of LGD-2226 may cause some undesirable side effects, such as headache, nausea, insomnia, etc. Therefore, before use, you should consult a doctor or professional for advice and use as directed. The recommend dose range should not be exceeded.
LGD-2226 are mainly used to strengthen muscle mass and strength, and are widely used in fitness and sports fields. Its mechanism of action is to promote muscle growth and repair by binding to androgen receptors in muscles and increasing protein synthesis.
As for the preparation method, the specific synthesis method of the LGD-2226 may be confidential commercial information, and I cannot provide a detailed preparation process.
Regarding safety information, there is no large-scale human trial data for reference. The use of LGD-2226 may cause some undesirable side effects, such as headache, nausea, insomnia, etc. Therefore, before use, you should consult a doctor or professional for advice and use as directed. The recommend dose range should not be exceeded.
Last Update：2024-04-10 22:29:15
Supplier List
Spot supply
Product Name: LGD-2226 Visit Supplier Webpage Request for quotationCAS: 328947-93-9
Tel: 609-228-6898
Email: sales@medchemexpress.com
tech@medchemexpress.com
Mobile: 609-228-6898
Spot supply
Product Name: LGD-2226 Visit Supplier Webpage Request for quotationCAS: 328947-93-9
Tel: 609-228-6898
Email: sales@medchemexpress.com
tech@medchemexpress.com
Mobile: 609-228-6898
View History
LGD-2226
1,3,3-Pyrrolidinetricarboxylic acid, 1-(1,1-dimethylethyl) 3,3-dimethyl ester
3-amino-6-ethyl-N-(4-methoxyphenethyl)-5,6,7,8-tetrahydrothieno[2,3-b]quinoline-2-carboxamide
1,2,4-Oxadiazole-3-carboxamide, 5-(aminomethyl)-N-methyl-
4-(4-chlorophenyl)-5-methyl-N-(2-naphthyl)-1,3-thiazol-2-amine
2-(1-naphthyl)-2-oxoethyl 2-(2-methoxyphenyl)-1,3-dioxoisoindoline-5-carboxylate
1,3,3-Pyrrolidinetricarboxylic acid, 1-(1,1-dimethylethyl) 3,3-dimethyl ester
3-amino-6-ethyl-N-(4-methoxyphenethyl)-5,6,7,8-tetrahydrothieno[2,3-b]quinoline-2-carboxamide
1,2,4-Oxadiazole-3-carboxamide, 5-(aminomethyl)-N-methyl-
4-(4-chlorophenyl)-5-methyl-N-(2-naphthyl)-1,3-thiazol-2-amine
2-(1-naphthyl)-2-oxoethyl 2-(2-methoxyphenyl)-1,3-dioxoisoindoline-5-carboxylate